NEVVI Medicare utilization intelligence
Market Brief J7799

Noc drugs, other than inhalation drugs, administered through dme

A national market document for J7799, CY2024 — dated, cited, vintage-stamped, methods attached, forwardable. 12–18 pages; 6–9 figures, set by this market’s shape.

Noc drugs, other than inhalation drugs, administered through dme · HCPCS J7799Nevvi Market Brief

What the data shows

The Brief is a national document for J7799. Its findings page carries one finding per chapter, each opening the chapter that prints its figure and the table behind it — like these, from the United States, CY2024, the market on this page.

  1. 1Size and growth. The national market for J7799 ran ~301 all-Medicare services (estimated), 150 observed fee-for-service in CY2024. The market is down 53.8% year over year. 1 billing group bill it.

What the Brief does not contain. Every table in the Brief is printed in it; nothing it rests on is held back. Figures cover Medicare fee-for-service claims; estimated all-Medicare figures are described in the methods.

This is a thin market on the record, so its Brief is a shorter document and says so. It carries the chapters the data supports — routed from this market's own record when the document is generated, never a fixed list. Every Brief also carries cover, findings, how-these-are-built, methods, appendix.

Two specimen briefs are free to read, whole, nothing removed: 99457 — remote monitoring → · 93000 — routine ECG →

← Back to the J7799 market on Nevvi — everything on that page stays free.